Kinase inhibition by PKC412 prevents epithelial sheet damage in autosomal dominant epidermolysis bullosa simplex via keratin and cell contact stabilization.

[1]  N. Gurskaya,et al.  Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex , 2021, International journal of molecular sciences.

[2]  E. Lane,et al.  A cell-based drug discovery assay identifies inhibition of cell stress responses as a new approach to treatment of epidermolysis bullosa simplex , 2021, Journal of cell science.

[3]  K. Sarin,et al.  Transcriptomic Repositioning Analysis Identifies mTOR Inhibitor as Potential Therapy for Epidermolysis Bullosa Simplex. , 2021, The Journal of investigative dermatology.

[4]  J. Fischer,et al.  Plantar involvement correlates with obesity, pain and impaired mobility in epidermolysis bullosa simplex: a retrospective cohort study , 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  A. Hovnanian,et al.  Emerging drugs for the treatment of epidermolysis bullosa , 2020, Expert opinion on emerging drugs.

[6]  C. Has,et al.  Severe skin fragility with postnatal lethal outcome due to a biallelic KRT5 mutation , 2020, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[7]  J. McGrath,et al.  Epidermolysis Bullosa , 2020, Braun-Falco´s Dermatology.

[8]  Graham F. Brady,et al.  Genotype‐phenotype analysis of LMNA‐related diseases predicts phenotype‐selective alterations in lamin phosphorylation , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  C. Bodemer,et al.  Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility , 2020, The British journal of dermatology.

[10]  J. Uitto,et al.  Biallelic KRT5 mutations in epidermolysis bullosa simplex, including a complete human keratin 5 "knock-out". , 2019, Matrix biology : journal of the International Society for Matrix Biology.

[11]  Richard C. Gerum,et al.  Treatment of keratinocytes with 4-phenylbutyrate in epidermolysis bullosa: Lessons for therapies in keratin disorders , 2019, EBioMedicine.

[12]  S. Tyring,et al.  Topical Diacerein Ointment for Epidermolysis Bullosa Simplex: A Review , 2019, Skin therapy letter.

[13]  Sabine Schmidt,et al.  FEM-based design of optical transparent indium tin oxide multielectrode arrays for multiparametric, high sensitive cell based assays. , 2019, Biosensors & bioelectronics.

[14]  A. Hovnanian,et al.  Epidermolysis bullosa simplex–generalized severe type due to keratin 5 p.Glu477Lys mutation: Genotype‐phenotype correlation and in silico modeling analysis , 2018, Pediatric dermatology.

[15]  F. Bérard,et al.  Epidermolysis bullosa simplex generalized severe induces a T helper 17 response and is improved by apremilast treatment , 2018, The British journal of dermatology.

[16]  A. Hovnanian,et al.  Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo‐controlled, double‐blind clinical trial , 2018, Journal of the American Academy of Dermatology.

[17]  A. Enomoto,et al.  Regulation of keratin 5/14 intermediate filaments by CDK1, Aurora-B, and Rho-kinase. , 2018, Biochemical and biophysical research communications.

[18]  R. Larson,et al.  Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. , 2018, Blood advances.

[19]  J. Jankowski,et al.  Threonine 150 Phosphorylation of Keratin 5 Is Linked to Epidermolysis Bullosa Simplex and Regulates Filament Assembly and Cell Viability. , 2017, The Journal of investigative dermatology.

[20]  J. Fischer,et al.  The Position of Targeted Next-generation Sequencing in Epidermolysis Bullosa Diagnosis. , 2018, Acta dermato-venereologica.

[21]  J. Reichelt,et al.  Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  V. Tedesco,et al.  Midostaurin, a Novel Protein Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia: Insights from Human Absorption, Metabolism, and Excretion Studies of a BDDCS II Drug , 2017, Drug Metabolism and Disposition.

[23]  M. Boerries,et al.  Monoallelic Mutations in the Translation Initiation Codon of KLHL24 Cause Skin Fragility. , 2016, American journal of human genetics.

[24]  J. McGrath,et al.  The p.Glu477Lys Mutation in Keratin 5 Is Strongly Associated with Mortality in Generalized Severe Epidermolysis Bullosa Simplex. , 2016, The Journal of investigative dermatology.

[25]  M. Omary,et al.  PKC412 normalizes mutation‐related keratin filament disruption and hepatic injury in mice by promoting keratin–myosin binding , 2015, Hepatology.

[26]  G. Dreissen,et al.  Distinct Impact of Two Keratin Mutations Causing Epidermolysis Bullosa Simplex on Keratinocyte Adhesion and Stiffness. , 2015, The Journal of investigative dermatology.

[27]  P. Coulombe,et al.  Complementary Roles of Specific Cysteines in Keratin 14 toward the Assembly, Organization, and Dynamics of Intermediate Filaments in Skin Keratinocytes* , 2015, The Journal of Biological Chemistry.

[28]  J. Waschke,et al.  A desmoplakin point mutation with enhanced keratin association ameliorates pemphigus vulgaris autoantibody-mediated loss of cell cohesion. , 2014, The American journal of pathology.

[29]  J. Wegener,et al.  Experimental tools to monitor the dynamics of endothelial barrier function: a survey of in vitro approaches , 2014, Cell and Tissue Research.

[30]  M. Omary,et al.  Post-translational modifications of intermediate filament proteins: mechanisms and functions , 2014, Nature Reviews Molecular Cell Biology.

[31]  T. Magin,et al.  Beyond expectations: novel insights into epidermal keratin function and regulation. , 2014, International review of cell and molecular biology.

[32]  T. Lettner,et al.  The pathogenetic role of IL-1β in severe epidermolysis bullosa simplex. , 2013, The Journal of investigative dermatology.

[33]  M. Tomita,et al.  Temporal Profiling of Lapatinib-suppressed Phosphorylation Signals in EGFR/HER2 Pathways* , 2012, Molecular & Cellular Proteomics.

[34]  Yuan Zhao,et al.  A dynamic real-time method for monitoring epithelial barrier function in vitro. , 2012, Analytical biochemistry.

[35]  Chang-Hun Lee,et al.  Defining keratin protein function in skin epithelia: Epidermolysis Bullosa Simplex and its aftermath , 2011, The Journal of investigative dermatology.

[36]  K. Green,et al.  Desmoplakin regulates desmosome hyperadhesion , 2011, The Journal of investigative dermatology.

[37]  C. Schiffer,et al.  Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia , 2012, Leukemia.

[38]  J. V. Van Eyk,et al.  Type I Keratin 17 Protein Is Phosphorylated on Serine 44 by p90 Ribosomal Protein S6 Kinase 1 (RSK1) in a Growth- and Stress-dependent Fashion* , 2011, The Journal of Biological Chemistry.

[39]  M. Omary,et al.  Keratin Hypersumoylation Alters Filament Dynamics and Is a Marker for Human Liver Disease and Keratin Mutation* , 2010, The Journal of Biological Chemistry.

[40]  M. Omary,et al.  Cytoskeletal keratin glycosylation protects epithelial tissue from injury , 2010, Nature Cell Biology.

[41]  M. Vaidya,et al.  O-GlcNAcylation Determines the Solubility, Filament Organization, and Stability of Keratins 8 and 18* , 2010, The Journal of Biological Chemistry.

[42]  E. Lane,et al.  ERK involvement in resistance to apoptosis in keratinocytes with mutant keratin. , 2010, The Journal of investigative dermatology.

[43]  M. Omary,et al.  Intermediate filaments take the heat as stress proteins. , 2010, Trends in cell biology.

[44]  E. Lane,et al.  The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases , 2008, Human mutation.

[45]  A. Merritt,et al.  Calcium-independent desmosomes of keratinocytes are hyper-adhesive. , 2007, The Journal of investigative dermatology.

[46]  M. Omary,et al.  A disease- and phosphorylation-related nonmechanical function for keratin 8 , 2006, The Journal of cell biology.

[47]  M. Omary,et al.  "Heads and tails" of intermediate filament phosphorylation: multiple sites and functional insights. , 2006, Trends in biochemical sciences.

[48]  E. Lane,et al.  Mechanical stress induces profound remodelling of keratin filaments and cell junctions in epidermolysis bullosa simplex keratinocytes , 2004, Journal of Cell Science.

[49]  R. Windoffer,et al.  Epidermolysis bullosa simplex-type mutations alter the dynamics of the keratin cytoskeleton and reveal a contribution of actin to the transport of keratin subunits. , 2003, Molecular biology of the cell.

[50]  Qin Zhou,et al.  Type II keratins are phosphorylated on a unique motif during stress and mitosis in tissues and cultured cells. , 2002, Molecular biology of the cell.

[51]  A. Harris,et al.  Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  H. Horn,et al.  The clinical spectrum of epidermolysis bullosa simplex , 2000, The British journal of dermatology.

[53]  T. Fleming,et al.  The alpha isoform of protein kinase C is involved in signaling the response of desmosomes to wounding in cultured epithelial cells. , 2000, Molecular biology of the cell.

[54]  K. Green,et al.  The Head Domain of Plakophilin-1 Binds to Desmoplakin and Enhances Its Recruitment to Desmosomes , 1999, The Journal of Biological Chemistry.

[55]  K. Green,et al.  The Amino-terminal Domain of Desmoplakin Binds to Plakoglobin and Clusters Desmosomal Cadherin–Plakoglobin Complexes , 1997, The Journal of cell biology.

[56]  P. Steinert,et al.  Two-hybrid Analysis Reveals Fundamental Differences in Direct Interactions between Desmoplakin and Cell Type-specific Intermediate Filaments* , 1997, The Journal of Biological Chemistry.

[57]  Y. Barrandon,et al.  A missense mutation in the rod domain of keratin 14 associated with recessive epidermolysis bullosa simplex , 1993, Nature Genetics.

[58]  E. Fuchs,et al.  The roles of K5 and K14 head, tail, and R/K L L E G E domains in keratin filament assembly in vitro , 1992, The Journal of cell biology.

[59]  K. Mckenna,et al.  Linkage of epidermolysis bullosa simplex to keratin gene loci. , 1992, Journal of medical genetics.

[60]  D. Bradley,et al.  Epidermolysis bullosa: evidence for linkage to genetic markers on chromosome 1 in a family with the autosomal dominant simplex form. , 1990, Genomics.

[61]  Y. Horiguchi,et al.  Epidermolysis Bullosa Simplex: Identification of a Kindred with Autosomal Recessive Transmission of the Weher‐Cockayne Variety , 1989, Pediatric dermatology.

[62]  P. Steinert,et al.  The dynamic phosphorylation of the human intermediate filament keratin 1 chain. , 1988, The Journal of biological chemistry.

[63]  A. Steven,et al.  Amino acid sequences of mouse and human epidermal type II keratins of Mr 67,000 provide a systematic basis for the structural and functional diversity of the end domains of keratin intermediate filament subunits. , 1985, The Journal of biological chemistry.

[64]  G. Sutherland,et al.  Genetic linkage analysis of epidermolysis bullosa simplex, Köbner type. , 1984, American journal of medical genetics.

[65]  W. Idler,et al.  Heterogeneity of intermediate filaments assembled in vitro. , 1982, Cold Spring Harbor symposia on quantitative biology.

[66]  P. Steinert,et al.  Structure of the three-chain unit of the bovine epidermal keratin filament. , 1978, Journal of molecular biology.